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Apoptosis in glomerular sclerosis
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Apoptosis in glomerular sclerosis. Glomeruloscierosis is characterized
by progressive extracellular matrix accumulation and glomerular cell loss.
The role of glomerular cell apoptosis in glomerulosclerosis was investi-
gated in the rat remnant kidney model and in human glomerular diseases.
We identified apoptotic cells in the glomeruli, tubules and interstitium in
the remnant kidney by electron microscopy. DNA fragmentation, which is
a biochemical characteristic of apoptosis, was detected by in Situ nick
end-labeling of fragmented DNA with terminal deoxynucleotidyl trans-
ferase and biotinylated deoxyuridine triphosphate. Fragmented DNA in
the glomeruli and tubules increased with the progression of glomerulo-
sclerosis in the remnant kidney model. This finding was also demonstrated
in other glomerular sclerotic lesions such as IgA and lupus nephritis. The
number of cells positive for nick end-labeling in the glomerulus signifi-
cantly correlated with the degree of glomerulosclerosis and the deterio-
ration of renal function. These results indicate that apoptosis is, at least in
part, involved in the cell deletion of various glomerular diseases leading to
sclerosis.
The accumulation of glomerular extracellular matrix (ECM)
and a decrease in glomerular cell number are prominent and
important pathologic features of progressive glomerulosclerosis
which results from a variety of glomerular injuries. The mecha-
nism of ECM accumulation has been well explored in recent
years. Growth factors, particularly transforming growth factor-a,
have been shown to participate in this mechanism [1, 21. In
contrast, the mechanism of cell death in the process of glomeru-
loscierosis is poorly understood.
Apoptosis is a type of cell death that plays an important role not
only in physiological processes such as embryogenesis, normal cell
turnover and endocrine-dependent tissue atrophy, but also in
some pathologic conditions such as tumor regression [3—7]. Ap-
optosis is an active form of cell death, that is, it requires some
specific protein production [8, 9]. It is morphologically distin-
guished from necrosis, which occurs in the accidental cell death
caused by noxious stimuli. During apoptosis, the nucleus of the
affected cells condenses and becomes fragmented and the cyto-
plasm also condenses. At the final stage of apoptosis, the cells
themselves are fragmented (apoptotic bodies) and are phagocy-
tosed by neighboring cells [3, 10]. Therefore, it is regarded as a
cell clearance mechanism [11]. Biochemically, it is accompanied
by activation of endonuclease and fragmentation of the DNA into
a ladder of regular subunits [12, 13]. Several genes involved in
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programmed cell death were recently identified in the embryonic
development of Caenorhabditis elegans [14]. Fas and Fas ligand,
the death factors, were involved not only in the development and
turnover of T cells, but also in cytotoxic T cell-mediated apoptosis
[15]. Thus, this regulated form of cell death has attracted wide
attention.
Apoptosis in renal disease has been mainly investigated in the
mechanism of tubular injuries [16]. For example, it has been
reported that cell deletion by apoptosis occurred in tubular
atrophy in experimental hydronephrosis [17]. Moreover, renal
ischemia and subsequent reperfusion initiated apoptosis in tubu-
lar cells [18]. In these situations apoptosis appears to be involved
in the pathogenesis of disease. However, there have been few
reports of cell death in the glomerulus. Harrison [19] first
reported the presence of apoptotic bodies in human glomerulo-
nephritis by light and electron microscopy. Within the past few
years, the involvement of apoptosis in glomerular diseases has
been pursued more actively. Two independent investigators [20,
21] reported recently that apoptosis was the major mechanism for
resolution of glomerular hypercellularity in Thy1. glomerulone-
phritis. They suggested that apoptosis was a homeostatic mecha-
nism controlling the size of the glomerular cell population and
clearing overproliferated cells. Their results suggest that deletion
by apoptosis of "unwanted" cells may be beneficial for the
glomerulus in self-limited mesangial proliferative nephritis.
However, apoptosis may also play a pathologic role which is not
always beneficial for the glomerulus. We hypothesized that apop-
tosis may be involved in the glomerular cell deletion of progres-
sive glomerulosclerosis. This hypothesis was tested in the rat
remnant kidney model and in human glomerulonephritis.
Methods
Disease model
Seven-week-old male Spragüe-Dawley rats, weighing approxi-
mately 200 g at the start of the experiments, were obtained from
Charles River Japan, Inc. (Atsugi, Kanagawa, Japan). They had
free access to standard rat chow and water throughout the
experimental period. Remnant kidneys were produced by ligation
of two branches of the left renal artery and subsequent right
unilateral nephrectomy in 15 rats [22]. The rats were subsequently
killed at week 4 and week 8. Ten rats in the control group
underwent laparotomy and manipulation of the renal pedicles but
without destruction of renal tissue. These procedures were per-
formed under anesthesia with 4 mg/100 g body wt of sodium
pentobarbital (Abbott Laboratories, North Chicago, IL, USA).
Serum creatinine concentration and 24-hour urinary protein
excretion were determined in each group at all time points.
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Sections were obtained from the kidneys of normal controls and
rats with 5/6 renal ablation, and were studied by light and electron
microscopy, and terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP-biotin nick end-labeling (TUNEL) method [23].
Human kidney tissues
Human kidney tissue specimens were obtained by percutaneous
renal biopsy. Tissue samples were taken from 9 patients with lupus
nephritis (LN) and 24 with primary immunoglobulin A (IgA)
nephropathy (IgAN). The diagnosis was confirmed on the basis of
clinical symptoms and immunofluorescence, light, and electron
microscopic findings.
Light microscopic studies
Removed rat or human kidney tissue was fixed in 10% buffered
formalin and embedded in paraffin. Three micrometer sections
were stained with periodic acid-Schiff (PAS) and hematoxylin and
eosin (HE). In the rat remnant kidney model, the percentage of
those exhibiting segmental sclerosis in 30 glomerular sections was
determined to be the sclerosis index. Sclerosis was evidenced by
an increase in mesangial matrix and/or collapse and condensation
of the glomerular basement membrane [24]. In human renal
biopsy specimens, each sample was assessed with respect to the
severity of pathologic features. Glomerular cell proliferation and
glomerular sclerosis were graded in each glomerulus semiquanti-
tatively from 0 to 3 as follows: glomerular cell proliferation, 0,
none; 1, proliferative changes in less than 25% of the glomerulus;
2, from 25% to 50%; 3, greater than 50%. Glomerular sclerosis
grading was: 0, none; 1, sclerotic changes in less than 25% within
the glomerulus; 2, from 25% to 50%; 3, greater than 50%. The
mean score per glomerulus in each patient was determined as the
glomerular proliferation or sclerosis index.
Electron microscopic studies
Electron microscopy was performed in the rat or human kidney
specimens as previously described [25]. In brief, tissue blocks of
kidney sections were immersed in 2.5% glutaraldehyde for two
hours at 4°C and postfixed with 1% osmium tetroxide. Some of the
blocks were then processed for routine dehydration, epon embed-
ding and thin sectioning, and examined with an electron micro-
scope.
TdT-mediated dUTP-biotin nick end labeling (TUNEL) method to
detect DNA fragmentation in tissue sections
DNA fragmentation associated with apoptosis was detected in
situ by the addition of biotinylated nucleotides to free 3' hydroxyl
groups in DNA according to the method of Gavrieli, Sherman and
Ben-Sasson [23], The formalin-fixed, paraffin-embedded sections
were deparaffinized, stripped of proteins by incubation with
proteinase K (20 j.tg/ml, Boehringer Mannheim/Yamanouchi,
Tokyo, Japan) for 20 minutes at room temperature (RT), and
then washed in distilled water (DW) three times for two minutes.
Endogenous peroxidase was inactivated by covering the sections
with 2% H202 for seven minutes. The sections were rinsed with
DW, immersed in terminal deoxynucleotidyl transferase (TdT)
buffer (Gibco, Gaithersburg, MD, USA), and then incubated with
TdT (0.3 e.u./j.tl, Gibco) and biotinylated dUTP (0.04 nmol/iil,
Boehringer MannheimlYamanouchi) at 37°C for 90 minutes. The
reaction was terminated by transferring the slides to TB buffer (30
Table 1. Indices of renal function and glomerular histology of control
and remnant kidney rats
Group Week 4 Week 8





















Values are mean SEM of five rats per group.
a CON, control grouphEXP, experimental group
P < 0.01 versus control at the same time point
m sodium citrate, 300 m sodium chloride) for 30 minutes at
RT. The sections were rinsed with DW, covered with 10% normal
rabbit serum for 10 minutes to block non-specific protein adsorp-
tion, rinsed with DW, and immersed in PBS. The slides were then
incubated with peroxidase-labeled streptavidin (Seikagaku Corp.,
Tokyo, Japan) for 30 minutes, washed in PBS, and finally stained
with 0.02% 3.3'-diaminobenzidine in 50 mivi Tris-HCI buffer
containing 0.02% H202 for 10 minutes at RT. Tissue sections for
the positive control were treated with proteinase K and peroxi-
dase inactivation as described above. They were pretreated with
DN buffer (30 mrvi Tris-HCI, pH 7.2, 140 m potassium cacody-
late, 4 mM MgC12), followed by DNase I (0.7 .tg/ml, Stratagene
Co., La Jolla, CA, USA) for 10 minutes at RT, and then nick
end-labeled as described above. The slides for the negative
control were treated likewise except for the use of buffer lacking
TdT.
Evaluation of the TUNEL method
In rat kidney samples, more than 30 glomerular cross-sections
and more than 200 tubular cross-sections were examined at each
animal in each time point. The number of positive-staining nuclei
per glomerulus was determined to be the glomerular TUNEL
score. In the tubules, the number of positive-staining nuclei per
tubular lumen in each section was evaluated as the tubular
TUNEL score. Glomerular TUNEL score was compared to the
histologic indices and clinical parameters in human studies.
Evaluation of clinical parameters
The clinical data obtained from the patients with various
glomerular diseases included serum creatinine concentration,
creatinine clearance and daily urinary protein excretion at the
time of the renal biopsy.
Statistical analysis
Statistical evaluation of the quantitative data from the animal
model was carried out by the Mann-Whitney U-test. The relation-
ship between the TUNEL score and the histologic indices or
clinical data were assessed by the analysis of variance. We
considered P values less than 0.05 to be significant.
Results
Development of glomeruloscierosis in the remnant kidney model
Table 1 shows the results of the laboratory and histologic data
in the experimental and control groups at different intervals following
surgery. The serum creatinine concentration was significantly higher
at week 8 in the experimental group when compared with that of
Fig. 1. Light micrographs of the glomendi from
experimental rats at 8 weeks after 5/6
nephrectomy. A. The accumulation of the
extracellular matrix and glomerular sclerosis are
noted. Apoptotic bodies (arrow) are found in
the sclerotic lesion. Inset. High magnification
view (x 1,000) of the apoptotic bodies. B. An
apoptotic cell (arrow) surrounded by an clear
vacuole is found in the expansion of the
mesangial matrix. Inset. High magnification
view (x 1,000) of the apoptotic cell. Arrowheads
indicate the margin of the clear vacuole. A, B;
HE stain, X400.
glomeruli with sclerotic changes increased significantly in the exper-
imental group at week 8.
Figure 1 indicates apoptosis in the glomeruli from experimental
group at week 8. The glomerulus of nephrectomized rats demon-
strated matrix accumulation and sclerosis. Apoptotic cells and
bodies appeared in sclerosis and in the expansion of matrix.
Apoptosis was not found in the glomeruli from control group at
any time point studied.
Given the lack of definitive molecular markers, morphologic
examination by electron microscopy is most definitive in confirm-
ing apoptosis [8]. We observed an apoptotic cell containing
condensed chromatin in the mesangium with a sclerotic lesion at
week 8 following nephrectomy by electron microscopy (Fig. 2).
Apoptosis of the tubular epithelial cells was also identified (Fig.
3). In the interstitium of the renal cortex, apoptotic cells, most
likely infiltrating cells, were recognized (Fig. 4).
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Fig. 2. Morphologic evidence of apoptosis in glomeruli of nephrectomized rats. An electron micrograph of the glomerulus from an experimental rat at 8
weeks after 5/6 nephrectomy is shown. Fragmented nuclei with condensed chromatin (arrow) is seen in the sclerotic lesion in the mesangium. MC:
mesangial cell; US: urinary space; Ep: epithelial cell. x8,700.
the control group. Massive proteinuria appeared and renal failure Electron microscopic evidence of apoptosis in the remnant kidney
developed in the experimental group at week 8. The percentage of
' 1, '4 —-
Fig. 3. Moiphologic evidence of apoptosis in tubules of nephrectomized rats. An electron micrograph of the tubules from an experimental rat at 8 weeks
after 5/6 nephrectomy is shown. There are four nuclei along the tubular lumen; the right upper nucleus (arrow) shows early changes of apoptosis with
crescentic chromatin compaction and cell shrinkage. TL: tubular lumen; TBM: tubular basement membrane. X6,000.
Fig. 4. Morphologic evidence of apoptosis in interstitium of the renal cortex of nephreclomized rats. An electron micrograph of the renal cortex from an
experimental rat at 8 weeks after nephrectomy is shown. Two apoptotic cells (arrows) contain nuclei with chromatin condensation in the intersitium of
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Fig. 5. TDT-mediated DNA nick end-labeling of
glomendi. Glomeruli from control (A, B) and
experimental rats at 8 weeks after nephrectomy
(C, D) are stained by the TUNEL method. A.
Positive control treated with DNase
demonstrates staining of almost all the cells in
the section. B. No staining is present in the
glomeruli of the control group. C., D. A few
TUNEL-positive nuclei (arrows) are present in
the glomeruli of the experimental group. A-D;
x400.
Fig. 6. TdT-T-mediated DNA nick end-labeling
of tubules. Tubules from control (A) and
experimental rats at 8 weeks after nephrectomy
(B, C, D) are stained by the TUNEL technique.
A. Positive control treated with DNase
demonstrates staining of almost all the cells in
the section. B. Three TUNEL-positive cells
(arrows) are recognized and one is detached in
the tubular lumen. C. There are clusters of
TUNEL-positive cells and most of them are
desquamated in the tubular lumen. D. A
TUNEL-positive cell (arrow) with a halo is
present in dilated and atrophic tubule. A-D;
x400.
Identification of fragmented DNA in the remnant kidney nique stained nearly all of the cells in the positive control sections
Since we found morphologic evidence of apoptosis by light and treated with DNase before the TdT reaction (Figs. 5A and 6A).
electron microscopy in the remnant kidney, we then used the No staining was present in the glomeruli of rats in the control
TUNEL method to detect DNA fragmentation [231 which is the group (Fig. 5B). The glomeruli of the remnant kidneys demon-
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Fig. 7. The number of TUNEL-positive cells in
the glomeruli (A) and tubules (B) of the rat
remnant kidney model. TUNEL-positive cells
significantly increase in te glomeruli (A) at 8
weeks after 5/6 nephrectomy. TUNEL-positive
cells significantly increase in the tubules (B) at
4 and 8 weeks after 5/6 nephrectomy. *p <
0.01. NS: not significant.
Table 2. Study population
Type of GN N Sex (M/F) Age (mean SD)
IgA nephropathy 24 10/14 26.8 14.3
Mild mesangial proliferation 8
Moderate mesangial proliferation 8
Predominantly sclerosing 8
Lupus nephritis 9 3/6 30.3 10.5
Diffuse LN (WHO IV) 8
Membranous LN (WHO V) I
Total 33 13/20
Abbreviation GN is glomerulonephritis.
Table 3. Histologic data of patients with lupus nephritis
Number of Proliferation Sclerosis TUNEL
Case Age/Sex glomeruli index index score
Diffuse LN (WHO IV)
1 22M 6 1.67 0.83 0.33
2 25M 4 2.25 0.50 1.00
3 36M 5 1.80 1.20 0.80
4 18F 9 2.78 0.00 0.33
5 23F 5 2.00 1.20 1.00
6 28F 3 0.67 1.00 0.00
7 41F 3 2.00 1.33 0.33
8 51F 7 0.86 2.14 1.43
Membranous LN (WHO V)
9 29F 3 0.00 0.00 0.00
In the tubules, the number of stained nuclei increased in the
experimental rats (Fig. 6 B-D). The number of apoptotic cells
significantly increased in the glomerulus at week 8 and in the
tubules at week 4 and at week 8 (Fig. 7).
DNA fragmentation in the diseased human kidney
The histologic diagnosis, sex and age of the patients are listed in
Table 2. Tables 3 and 4 represent the histologic indices and
glomerular TUNEL score in each patient. TUNEL-positive cells
were recognized in 7 of 9 patients (78%) with LN and in 14 of 24
patients (58%) with IgAN (Tables 3 and 4). The TUNEL method
stained shrunken cells in a glomerular sclerotic lesion in LN or in
a sclerotic glomerulus in IgAN, which appeared typical of apo-
ptotic cells compared to the HE stain on the serial section (Fig. 8).










1 18M 3 0.50 0.00 0.00
2 20M 11 0.18 0.00 0.18
3 20M 14 0.29 0.00 0.00
4 71M 3 0.00 0.00 0.00
5 20F 15 0.33 0.40 0.00
6 21F 3 0.67 0.00 0.00
7 28F 7 0.43 0.57 0.14
8 61F 10 0.40 0.50 0.10
Moderate mesangial proliferation
9 18M 10 1.00 0.56 0.00
10 22M 4 1.11 0.22 0.00
11 13F 5 1.00 0.60 0.00
12 14F 11 1.55 0.09 0.27
13 19F 7 1.14 0.00 0.00
14 26F 7 0.71 0.29 0.14
15 26F 7 1.29 0.57 0.43
16 40F 4 1.25 0.50 0.25
Predominantly sclerosing
17 17M 6 0.00 2.50 0.17
18 20M 3 1.00 1.00 0.33
19 23M 3 0.33 1.67 1.00
20 29M 10 0.45 1.18 0.00
21 15F 5 1.00 1.00 0.20
22 23F 2 0.50 2.50 1.00
23 38F 7 0.00 2.63 0.14
24 40F 5 0.20 1.80 0.20
Correlation between apoptosis, histologic and clinical parameters
The number of TUNEL-positive cells in the glomeruli was
compared with the histologic indices and clinical data. The
glomerular TUNEL score correlated significantly with the gb-
merular sclerosis index in 24 patients with IgAN (P = 0.0073) and
in 9 patients with LN (P = 0.0357; Table 5). This score also
correlated significantly with 24-hour creatinine clearance in pa-
tients with IgAN (P = 0.0365) and with serum creatinine concen-
tration in patients with LN (P = 0.0374; Table 5). There was no
correlation between the gbomerular TUNEL score, proliferation
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Fig. 8. Appearance of apoptosis in the glomeruli
of patients with diffuse proliferative lupus nephritis
(A, B, 23 years old, female) and with IgA
nephropathy (C, D, 23 years old, male). The
glomerulus staind by TUNEL method (A, C) or
by hematoxylin and eosin (B, D) on the serial
section is shown. A. A TUNEL-positive cell
(arrow) is observed in the sclerotic lesion. B.
The TUNEL-positive cell in A is an apoptotic
cell surrounded by a clear vacuole (arrow). C.
A positive cell (arrow) is observed in a sclerotic
glomerulus. D. The same cell as C is indicated
by an arrow. g: glomerulus. A-D; X400.
Table 5. The correlation between glomerular TUNEL score and













IgA nephropathy NS P < 0.01 NS NS P < 0.05
Lupus nephritis NS P < 0.05 NS P < 0.05 NS
Abbreviations are: GN, glomerulonephritis; NS, not significant.
Discussion
In the presence of global glomerulosclerosis, the glomerular
cells are replaced by the ECM. Therefore, glomerulosclerosis is a
progressive decrease in the number of glomerular cells and
increase in glomerular ECM. The basic mechanisms of this
progressive loss remains unknown. We hypothesized that apopto-
sis was involved in this progressive cell deletion and tested this
hypothesis using the rat remnant kidney model and human renal
biopsy specimens.
Recently several enzymatic techniques have been developed to
detect DNA fragmentation at the cellular level on tissue sections
[23, 26, 27]. Theoretically, TdT incorporates nucleotides from the
3' OH-terminus into fragmented DNA of apoptotic cells [23].
This molecular technique detects not only apoptotic DNA but
also random DNA fragmentation occurring in late stages of
necrosis [27]. Therefore the TUNEL method should be combined
with the analysis of nuclear morphology as we examined the
conventional HE stain on the serial section (Fig. 8). TUNEL was
utilized for detection of glomerular apoptosis in recent studies
[20, 21].
Cell death has been documented in the diseased glomerulus
[19—21, 28]. Harrison has observed apoptotic bodies in human
glomerulonephritis by light and electron microscopy [19]. He
identified numerous neutrophils undergoing apoptosis in severe
proliferative glomerulonephritis. This observation led to the spec-
ulation that apoptosis is involved in the reduction of acute
glomerular damage, allowing a hypercellular glomerulus to return
to normal. Savill et al have reported that apoptosis in neutrophils
lead to its recognition and phagocytosis not only by inflammatory
macrophages but also by glomerular mesangial cells in the rat
model of nephrotoxic nephritis [28]. Recently Baker et al [20] and
Shimizu et a! [21] have reported that apoptosis was the major
mechanism for the resolution of glomerular hypercellularity in
Thyl.1 glomerulonephritis. They also have demonstrated that
mesangial apoptosis may be engaged as a homeostatic mechanism
controlling the size of the glomerular cell population and promot-
ing resolution of the mesangial proliferation. These studies
suggest that deletion of "unwanted" cells by apoptosis may be
110 Sugiyama et al: Apoptosis in glomendoscierosis
beneficial for the glomerulus in self-limited proliferative glomer-
ulonephritis.
However, apoptosis was associated with glomerular cell dele-
tion and ECM accumulation in the late stages of glomeruloscle-
rosis after the early transient cell proliferation in the rat remnant
kidney model. In this model, the number of glomerular apoptotic
cells increased with the progression of glomeruloscierosis. In
human glomerulonephritis including LN and IgAN, apoptotic
cells were visualized in the glomeruli. The number of glomerular
apoptotic cells correlated with the glomerular sclerosis index and
deterioration of renal function. We also recognized TUNEL-
positive cells in glomeruli of patients with focal glomerulosclerosis
(unpublished observations). These results suggest that apoptosis
is, at least in part, one of the mechanisms of glomerular cell
deletion during progressive glomerulosclerosis. Moreover, apo-
ptosis may also play a pathologic role which is not always
beneficial for the glomerulus.
The renal glomerulus is composed of three types of resident
cells, primarily the mesangial, endothelial and epithelial cells [291.
In addition, inflammatory leukocytes infiltrate the diseased gb-
merulus. The type of apoptotic cells is important but difficult to
determine, because the morphology of the apoptotic cell is
uniform regardless of cell type [3—5, 7]. Moreover, apoptotic cells
are so rapidly phagocytosed and ingested that they do not
maintain their original structures and distinctive markers of cell
origin [11]. We can presume the origin of apoptotic cells from
where the lesions are located. We also demonstrated that apop-
tosis occurs in the glomerular mesangium with ECM accumula-
tion but not in the glomerular capillaries by light and electron
microscopy. This observation suggests that at least one of the
apoptotic cells is the mesangial cell.
The signal that induces apoptosis of glomerular cells in pro-
gressive glomeruloscierosis remains elusive. One candidate is the
reactive oxygen species (ROS). ROS may induce apoptosis in
cultured mesangial cells [30]. Moreover, ROS are commonly
known to be important mediators implicated in the pathophysiol-
ogy of glomerular diseases [31—33], such as neutrophil-mediated
glomerular injury [34], puromycin aminonucleoside nephrosis
[35], diabetic glomerulosclerosis and progressive renal injury [36].
ROS also plays an intermediate role in tubular injuries [161. Cell
deletion by apoptosis has been reported in tubular atrophy [171
and in ischemia-reperfusion injury of tubular cells [18]. In these
situations, apoptosis may be involved in the pathogenesis of
disease. In cultured tubular epithelial cells exposed to H202,
endonuclease activation occurs as an early event leading to DNA
damage and cell death [37]. Therefore, ROS are considered to be
one of the mediators of tubular cell apoptosis. Another candidate
is the depletion of nutrients and survival factors caused by
capillary collapse and abnormal ECM accumulation in the gb-
merulus. The mechanism of apoptosis occurring in vivo should be
extensively investigated utilizing renal cell culture techniques and
analyzing disease models.
The mechanism of glomerular cell loss in progressive glomer-
ulosclerosis has been given minimal attention until now. Our study
demonstrates apoptosis to be involved in this process. Both cell
death and proliferation should be considered in the study of
glomerulonephritis and subsequent glomeruloscierosis. This ap-
proach may prove to be effective in the prevention of glomerulo-
sclerosis and end-stage renal failure.
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